Tag: Geng Ke
Luzhu Biotechnology launches HKD341m IPO via chapter 18A
Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million
O’Melveny acts on Acotec Scientific’s partial offering
O’Melveny advised China’s medical technology company, Acotec Scientific Holdings, on the voluntary partial offer for a majority stake of up to 65% by US-listed Boston Scientific Group
The A-List 2022
After thorough editorial survey and research, China Business Law Journal presents the elite lawyers in China’s legal market
LATEST ON VANTAGE ASIA
Counsel in command
Japan's GC association president shares evolving in-house lawyer roles
